DNA-PK deficiency potentiates cGAS-mediated antiviral innate immunity.
Animals
Antiviral Agents
/ metabolism
Cell Line
Chromones
/ pharmacology
DNA-Activated Protein Kinase
/ antagonists & inhibitors
Female
Fibroblasts
/ drug effects
Humans
Immunity, Innate
Male
Mice, Inbred C57BL
Morpholines
/ pharmacology
Nucleotidyltransferases
/ metabolism
Phosphorylation
/ drug effects
Protein Kinase Inhibitors
/ pharmacology
Protein Multimerization
/ drug effects
RNA, Guide, Kinetoplastida
/ metabolism
Signal Transduction
/ drug effects
Simplexvirus
/ drug effects
THP-1 Cells
Vesiculovirus
/ drug effects
Virus Replication
/ drug effects
Journal
Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555
Informations de publication
Date de publication:
03 12 2020
03 12 2020
Historique:
received:
05
02
2020
accepted:
09
11
2020
entrez:
4
12
2020
pubmed:
5
12
2020
medline:
17
12
2020
Statut:
epublish
Résumé
Upon sensing cytosolic DNA, the enzyme cGAS induces innate immune responses that underpin anti-microbial defenses and certain autoimmune diseases. Missense mutations of PRKDC encoding the DNA-dependent protein kinase (DNA-PK) catalytic subunit (DNA-PKcs) are associated with autoimmune diseases, yet how DNA-PK deficiency leads to increased immune responses remains poorly understood. In this study, we report that DNA-PK phosphorylates cGAS and suppresses its enzymatic activity. DNA-PK deficiency reduces cGAS phosphorylation and promotes antiviral innate immune responses, thereby potently restricting viral replication. Moreover, cells isolated from DNA-PKcs-deficient mice or patients carrying PRKDC missense mutations exhibit an inflammatory gene expression signature. This study provides a rational explanation for the autoimmunity of patients with missense mutations of PRKDC, and suggests that cGAS-mediated immune signaling is a potential target for therapeutic interventions.
Identifiants
pubmed: 33273464
doi: 10.1038/s41467-020-19941-0
pii: 10.1038/s41467-020-19941-0
pmc: PMC7712783
doi:
Substances chimiques
8-dibenzothiophen-4-yl-2-morpholin-4-yl-chromen-4-one
0
Antiviral Agents
0
Chromones
0
Morpholines
0
Protein Kinase Inhibitors
0
RNA, Guide
0
DNA-Activated Protein Kinase
EC 2.7.11.1
Nucleotidyltransferases
EC 2.7.7.-
cGAS protein, human
EC 2.7.7.-
cGAS protein, mouse
EC 2.7.7.-
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
6182Subventions
Organisme : NCI NIH HHS
ID : R01 CA221521
Pays : United States
Organisme : NIDCR NIH HHS
ID : R35 DE027556
Pays : United States
Organisme : NIAID NIH HHS
ID : R21 AI134105
Pays : United States
Organisme : NIDCR NIH HHS
ID : R01 DE026003
Pays : United States
Références
Clin Immunol. 2018 Dec;197:1-5
pubmed: 30121298
Elife. 2012 Dec 18;1:e00047
pubmed: 23251783
Elife. 2018 Oct 08;7:
pubmed: 30295605
Cell Mol Immunol. 2018 Jul;15(7):666-675
pubmed: 29456253
Cell. 2019 Mar 7;176(6):1432-1446.e11
pubmed: 30827685
Cell Rep. 2014 Feb 13;6(3):421-30
pubmed: 24462292
Nat Commun. 2018 Aug 22;9(1):3349
pubmed: 30135424
J Clin Invest. 2013 Jul;123(7):2969-80
pubmed: 23722905
Cell. 2019 Mar 7;176(6):1447-1460.e14
pubmed: 30799039
Immunity. 2016 Sep 20;45(3):555-569
pubmed: 27637147
J Virol. 2017 Feb 28;91(6):
pubmed: 28077645
Nature. 2015 Apr 23;520(7548):553-7
pubmed: 25642965
Proc Natl Acad Sci U S A. 2015 Oct 20;112(42):E5699-705
pubmed: 26371324
Cell Rep. 2015 Oct 13;13(2):440-9
pubmed: 26440888
Immunity. 2008 Oct 17;29(4):538-50
pubmed: 18818105
J Exp Med. 2017 Nov 6;214(11):3279-3292
pubmed: 28951494
Cell Host Microbe. 2018 Aug 8;24(2):234-248.e5
pubmed: 30092200
J Clin Invest. 2009 Jan;119(1):91-8
pubmed: 19075392
PLoS Pathog. 2017 Mar 8;13(3):e1006264
pubmed: 28273161
J Exp Med. 2018 May 7;215(5):1287-1299
pubmed: 29622565
PLoS Pathog. 2014 Apr 17;10(4):e1003989
pubmed: 24743339
Cell Host Microbe. 2016 Feb 10;19(2):150-8
pubmed: 26867174
N Engl J Med. 2014 Aug 7;371(6):507-518
pubmed: 25029335
Sci Immunol. 2020 Jan 24;5(43):
pubmed: 31980485
Nat Genet. 2006 Aug;38(8):917-20
pubmed: 16845398
Nature. 2017 Aug 24;548(7668):461-465
pubmed: 28738408
Annu Rev Cell Dev Biol. 2018 Oct 6;34:357-379
pubmed: 30095291
Mol Cell. 2014 Apr 24;54(2):289-96
pubmed: 24766893
PLoS One. 2013 Nov 25;8(11):e80313
pubmed: 24282534
Cell. 2013 May 23;153(5):1094-107
pubmed: 23647843
PLoS Pathog. 2015 Jul 29;11(7):e1005060
pubmed: 26221961
Nature. 2014 Jan 30;505(7485):691-5
pubmed: 24284630
Cell Host Microbe. 2015 Sep 9;18(3):333-44
pubmed: 26320998
J Immunol. 2014 Jun 15;192(12):5993-7
pubmed: 24813208
Nat Cell Biol. 2017 Sep;19(9):1061-1070
pubmed: 28759028
Cell. 1995 Mar 10;80(5):813-23
pubmed: 7889575
Science. 2013 Feb 15;339(6121):786-91
pubmed: 23258413
Nat Immunol. 2016 Sep 20;17(10):1142-9
pubmed: 27648547
J Virol. 2014 Jan;88(2):974-81
pubmed: 24198409
DNA Repair (Amst). 2014 May;17:21-9
pubmed: 24680878
Nat Commun. 2017 Sep 29;8(1):750
pubmed: 28963528
J Allergy Clin Immunol. 2015 Jun;135(6):1578-88.e5
pubmed: 25842288
PLoS One. 2017 Sep 21;12(9):e0184843
pubmed: 28934246
Proc Natl Acad Sci U S A. 2012 Nov 20;109(47):19386-91
pubmed: 23132945
Science. 2018 Aug 17;361(6403):704-709
pubmed: 29976794
Cell Rep. 2016 Jul 12;16(2):405-418
pubmed: 27346349
Nature. 2018 Jul;559(7713):269-273
pubmed: 29973723
Science. 2013 Sep 20;341(6152):1390-4
pubmed: 23989956
Nature. 2008 Oct 2;455(7213):674-8
pubmed: 18724357
Nat Immunol. 2016 Apr;17(4):369-78
pubmed: 26829768
PLoS Pathog. 2015 Jun 24;11(6):e1005001
pubmed: 26107716
PLoS Pathog. 2015 Mar 26;11(3):e1004768
pubmed: 25811856
Nat Microbiol. 2017 Mar 27;2:17037
pubmed: 28346446